Decitabine Is Effective and Safe In Patients with Chronic Myelomonocytic Leukemia.

被引：0
|
作者：
Jabbour, Elias [1 ]
Kantarjian, Hagop M. [1 ]
Ravandi, Farhad [1 ]
Cornelison, A. Megan [1 ]
Kadia, Tapan [1 ]
Borthakur, Cautam [1 ]
Cortes, Jorge E. [1 ]
Garcia-Manero, Guillermo [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1644 / 1644
页数：1
相关论文
共 50 条
  • [1] Chronic myelomonocytic leukemia.
    Bennett J.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 221 - 223
  • [2] Decitabine, a potential targeted therapeutic for juvenile myelomonocytic leukemia.
    Liu, YL
    Emanuel, PD
    Castleberry, RP
    BLOOD, 2005, 106 (11) : 706A - 707A
  • [3] Decitabine In Advanced Chronic Myelomonocytic Leukemia
    Santini, Valeria
    Allione, Bernardino
    Levis, Alessandro
    Gioia, Daniela
    Lunghi, Mania
    Poloni, Antonella
    Cilloni, Daniela
    Zini, Gina
    Sanna, Alessandro
    Rossi, Alessia
    Terenzi, Adelmo
    Angelucci, Emanuele
    Finelli, Carlo
    Onida, Francesco
    Rossi, Giuseppe
    Ferrero, Dario
    Saglio, Giuseppe
    Masiera, Elisa
    BLOOD, 2013, 122 (21)
  • [4] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
    Wijermans, P. W.
    Luebbert, Michael
    Baer, Maria R.
    Slack, James L.
    BLOOD, 2006, 108 (11) : 756A - 757A
  • [5] Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
    Wijermans, P. W.
    Rueter, B.
    Baer, M. R.
    Slack, J. L.
    Saba, H. I.
    Luebbert, M.
    LEUKEMIA RESEARCH, 2008, 32 (04) : 587 - 591
  • [6] Efficacy of decitabine in advanced chronic myelomonocytic leukemia (CMML) patients
    Santini, V.
    Allione, B.
    Lunghi, M.
    Levis, A.
    Poloni, A.
    Angelucci, E.
    Onida, F.
    Terenzi, A.
    Finelli, C.
    Ferrero, D.
    LEUKEMIA RESEARCH, 2013, 37 : S17 - S17
  • [7] Activity of azacitidine in chronic myelomonocytic leukemia.
    Costa, R. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia
    Aribi, Ahmed
    Borthakur, Gautam
    Ravandi, Farhad
    Shan, Jianqin
    Davisson, Jan
    Gortes, Jorge
    Kantarjian, Hagop
    CANCER, 2007, 109 (04) : 713 - 717
  • [9] Molecular Determinants of Decitabine Response in Chronic Myelomonocytic Leukemia
    Rossi, Alessia
    Meldi, Kristen
    Martinez, Ana Belen Valencia
    Abdel-Wahab, Omar
    Micol, Jean Baptiste
    Qin Tingting
    Buchi, Francesca
    Masala, Erico
    Sanna, Alessandro
    Allione, Bernardino
    Lunghi, Monia
    Onida, Francesco
    Poloni, Antonella
    Angelucci, Emanuele
    Finelli, Carlo
    Levis, Alessandro
    Gioia, Daniela
    Figueroa, Maria E.
    Santini, Valeria
    BLOOD, 2014, 124 (21)
  • [10] Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia
    Molina, John C.
    Asare, Julie M.
    Tuschong, Laura
    West, Robert R.
    Calvo, Katherine R.
    Persky, Rebecca
    Boyce, Alison M.
    Hammoud, Dima A.
    Holland, Steven M.
    Hickstein, Dennis
    Shah, Nirali N.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (03)
12345